SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-11.22%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$253M
AUM Growth
+$253M
(-5.6%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-42.34%
Top 10 Holdings %
Top 10 Hldgs %
44%
Holding
60
New
10
Increased
18
Reduced
9
Closed
21
Top Buys
| 1 |
Cencora
COR
|
$12.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11M |
| 3 |
McKesson
MCK
|
$9.22M |
| 4 |
Novo Nordisk
NVO
|
$8.16M |
| 5 |
Encompass Health
EHC
|
$7.73M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$82.9M |
| 2 |
Tenet Healthcare
THC
|
$27.6M |
| 3 |
AbbVie
ABBV
|
$14M |
| 4 |
Baxter International
BAX
|
$12.5M |
| 5 |
Elevance Health
ELV
|
$8.31M |
Sector Composition
| 1 | Healthcare | 98.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
IQVIA
IQV
$32.4B
| – | – |
-35,000
| Closed | -$5.41M |
|
52
Johnson & Johnson
JNJ
$427B
| – | – |
-35,000
| Closed | -$5.11M |
|
53
Labcorp
LH
$23.1B
| – | – |
-25,000
| Closed | -$4.23M |
|
54
Medtronic
MDT
$119B
| – | – |
-45,000
| Closed | -$5.11M |
|
|
SAGE
55
DELISTED
Sage Therapeutics
SAGE
| – | – |
-15,000
| Closed | -$1.08M |
|
56
Sanofi
SNY
$121B
| – | – |
-150,000
| Closed | -$7.53M |
|
57
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
58
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-22,500
| Closed | -$2.9M |
|
59
Zoetis
ZTS
$69.3B
| – | – |
-40,000
| Closed | -$5.29M |
|
|
SGEN
60
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-19,500
| Closed | -$2.23M |
|